PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
19893044-6	2009	Bleomycin-treated CD103(-/-) mice had persistent neutrophilic inflammation, increased fibrosis, and increased mortality compared with wild-type mice, a phenotype that was partially recapitulated in bleomycin/nFMLP-treated Mmp7(-/-) mice.	Bleomycin	0-9	integrin alpha E, epithelial-associated	Mus musculus	18-23	
19893044-6	2009	Bleomycin-treated CD103(-/-) mice had persistent neutrophilic inflammation, increased fibrosis, and increased mortality compared with wild-type mice, a phenotype that was partially recapitulated in bleomycin/nFMLP-treated Mmp7(-/-) mice.	Bleomycin	198-207	integrin alpha E, epithelial-associated	Mus musculus	18-23	
34478832-9	2022	Additionally, LDLR (1.0 Gy) significantly reduced bleomycin-induced increases in interstitial macrophages, CD103+ dendritic cells and neutrophil-DC hybrids.	Bleomycin	50-59	integrin alpha E, epithelial-associated	Mus musculus	107-112	
34478832-13	2022	Mechanistically, LDLR at 1.0 Gy significantly suppressed bleomycin-induced accumulation of pulmonary interstitial macrophages, CD103+ dendritic cells and neutrophil-DC hybrids.	Bleomycin	57-66	integrin alpha E, epithelial-associated	Mus musculus	127-132	
31959382-3	2020	OBJECTIVE: We investigated the impact of CD103 loss on bleomycin-induced skin fibrosis because CD103 is a critical molecule determining DC phenotypes.	Bleomycin	55-64	integrin alpha E, epithelial-associated	Mus musculus	41-46	
31959382-4	2020	METHODS: Bleomycin-induced skin fibrosis was generated with Cd103-/- mice.	Bleomycin	9-18	integrin alpha E, epithelial-associated	Mus musculus	60-65	
31959382-7	2020	RESULTS: CD103 loss decreased bleomycin-induced dermal thickness and collagen contents, along with TGF-beta1 and CTGF suppression.	Bleomycin	30-39	integrin alpha E, epithelial-associated	Mus musculus	9-14	
31959382-8	2020	Treg proportion was increased, while Th1/Th2/Th17 cell proportions were decreased in the skin of bleomycin-treated Cd103-/- mice.	Bleomycin	97-106	integrin alpha E, epithelial-associated	Mus musculus	115-120	
31959382-9	2020	Bleomycin injection enhanced CD11b-CD103- DC proportion in wild-type mice, which was further augmented in Cd103-/- mice.	Bleomycin	0-9	integrin alpha E, epithelial-associated	Mus musculus	35-40	
31959382-9	2020	Bleomycin injection enhanced CD11b-CD103- DC proportion in wild-type mice, which was further augmented in Cd103-/- mice.	Bleomycin	0-9	integrin alpha E, epithelial-associated	Mus musculus	106-111	
31959382-10	2020	Importantly, RALDH1/ALDH1A1 enzyme oxidizing retinaldehyde to retinoic acid, an inducer of Tregs, was preferentially expressed by CD11b-CD103- DCs and its expression levels were elevated in bleomycin-injected skin lesions, to a greater extent in Cd103-/- mice than in wild-type mice.	Bleomycin	190-199	integrin alpha E, epithelial-associated	Mus musculus	136-141	
31959382-10	2020	Importantly, RALDH1/ALDH1A1 enzyme oxidizing retinaldehyde to retinoic acid, an inducer of Tregs, was preferentially expressed by CD11b-CD103- DCs and its expression levels were elevated in bleomycin-injected skin lesions, to a greater extent in Cd103-/- mice than in wild-type mice.	Bleomycin	190-199	integrin alpha E, epithelial-associated	Mus musculus	246-251